BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR HIST CENTRE GG GRADE HISTO AGE SIZE MM MENOP COMORB HER2 NODES GGI ER
GSM1061142 1 lobular 1 equivocal 2 80 15 postmenopausal average for age 0 0 -0.3 1
GSM106114 1 ductal 1 equivocal 1 75 10 postmenopausal minor 0 0 0.2 1
GSM1061140 0 ductal 1 3 3 42 17 premenopausal minor 0 0 2 1
GSM1061139 1 ductal 1 1 1 51 11 postmenopausal minor 0 0 -1.5 1
GSM1061138 1 ductal 1 3 3 41 16 NA minor 1 0 0.6 1
GSM1061137 0 ductal 6 3 3 48 28 premenopausal perfect health 0 0 3.1 1
GSM1061136 1 ductal 6 3 3 60 8 postmenopausal perfect health 1 0 0.5 1
GSM1061135 0 ductal 6 1 1 56 12 NA perfect health 0 0 -0.6 1
GSM1061134 0 ductal 6 3 2 78 45 postmenopausal major problems 0 1 0.4 1
GSM1061133 1 ductal 6 1 2 43 12 premenopausal perfect health 0 0 -0.7 1
GSM1061132 1 ductal 6 3 2 69 42 NA perfect health 0 2 1.4 1
GSM106113 0 ductal 6 1 2 53 18 NA perfect health 0 0 -0.6 1
GSM1061130 1 lobular 6 1 3 54 32 postmenopausal perfect health 1 0 -0.7 1
GSM1061129 1 ductal 6 1 2 63 35 NA major problems 0 0 -1.1 1
GSM1061128 0 ductal 6 3 3 38 17 premenopausal perfect health 0 0 2.4 0
GSM1061127 1 ductal 6 3 3 70 45 postmenopausal major problems 0 1 1.6 1
GSM1061126 1 lobular 3 1 2 53 8 postmenopausal minor 0 0 -1.2 1
GSM1061125 1 ductal 3 equivocal 2 62 15 postmenopausal minor 0 0 -0.3 1
GSM1061124 1 ductal 3 equivocal 2 58 18 postmenopausal minor 0 1 0.1 1
GSM1061123 1 ductal 3 1 1 51 12 postmenopausal minor 0 0 -1 1
GSM1061122 1 ductal 1 equivocal 2 43 13 premenopausal minor 0 0 -0.1 1
GSM106112 1 lobular 6 1 1 56 20 postmenopausal minor 0 0 -1 1
GSM1061120 0 ductal 6 3 3 45 13 premenopausal perfect health 0 1 1.2 1
GSM1061119 1 ductal 6 1 2 64 6 postmenopausal major problems 0 0 -1.9 1
GSM1061118 0 ductal 6 3 3 87 45 postmenopausal major problems 1 0 1.9 0
GSM1061117 1 ductal 6 1 2 51 13 NA minor 0 1 -0.4 1
GSM1061116 1 lobular 6 1 2 67 30 postmenopausal minor 0 0 -2.3 1
GSM1061115 1 ductal 6 1 1 84 13 postmenopausal average for age 0 0 -0.8 1
GSM1061114 0 ductal 9 3 2 56 9 postmenopausal perfect health 0 0 0.8 0
GSM1061113 0 ductal 9 3 3 47 33 premenopausal perfect health 0 0 3.3 0
GSM1061112 1 ductal 9 1 1 78 17 postmenopausal perfect health 0 0 -0.5 1
GSM106 0 ductal 6 3 3 76 30 postmenopausal NA 1 2 1.6 0
GSM1061110 1 ductal 6 equivocal 2 53 15 NA major problems 0 0 -0.1 1
GSM1061109 1 lobular 6 1 1 52 12 premenopausal major problems 0 0 -2.3 1
GSM1061108 1 ductal 6 1 2 47 16 NA minor 0 0 -1.5 1
GSM1061107 1 ductal 6 3 1 49 15 premenopausal major problems 0 0 1 1
GSM1061106 1 ductal 6 3 2 58 15 NA perfect health NA 0 0.7 1
GSM1061105 1 ductal 6 3 3 77 22 postmenopausal minor 0 3 1.3 1
GSM1061104 0 ductal 6 equivocal 2 60 9 postmenopausal minor 0 0 0.1 1
GSM1061103 0 ductal 6 3 2 75 25 postmenopausal average for age 0 2 0.9 1
GSM1061102 1 ductal 6 3 3 63 18 NA minor 1 1 0.8 1
GSM106110 1 ductal 6 1 2 66 15 postmenopausal perfect health 0 0 -0.6 1
GSM1061100 0 ductal 6 3 3 49 15 premenopausal perfect health 1 2 0.8 0
GSM1061099 1 ductal 9 3 2 47 20 premenopausal perfect health 0 0 0.4 1
GSM1061098 1 ductal 9 3 2 55 17 postmenopausal perfect health 0 0 2 1
GSM1061097 0 ductal 9 3 2 44 26 premenopausal perfect health 0 0 0.7 1
GSM1061096 1 ductal 9 1 2 64 13 postmenopausal perfect health 0 0 -1 1
GSM1061095 0 ductal 9 3 2 64 32 postmenopausal perfect health 0 1 0.4 1
GSM1061094 1 ductal 9 1 1 49 21 premenopausal perfect health 0 0 -0.6 1
GSM1061093 1 ductal 9 1 2 44 15 premenopausal perfect health 0 0 -0.6 1
GSM1061092 1 ductal 9 3 2 44 25 premenopausal perfect health 0 0 1.1 1
GSM106109 1 lobular 9 1 2 42 17 premenopausal perfect health 0 0 -1.2 1
GSM1061090 0 ductal 9 3 3 31 23 premenopausal perfect health 0 0 2.8 0
GSM1061089 1 ductal 9 equivocal 2 53 19 premenopausal perfect health 0 0 -0.1 1
GSM1061088 0 lobular 9 1 3 82 27 postmenopausal average for age 0 0 -0.3 0
GSM1061087 1 ductal 9 1 1 64 12 postmenopausal perfect health 0 0 -0.8 1
GSM1061086 1 ductal 9 1 2 61 15 postmenopausal perfect health 0 0 -0.4 1
GSM1061085 0 lobular 9 3 3 73 22 postmenopausal perfect health 0 0 0.4 1
GSM1061084 0 ductal 9 3 3 82 22 postmenopausal average for age 1 0 0.4 0
GSM1061083 1 ductal 9 1 2 65 11 postmenopausal perfect health 0 1 -2.2 1
GSM1061082 0 ductal 9 3 3 35 22 premenopausal perfect health 0 1 2.9 1
GSM106108 1 ductal 2 equivocal 2 61 25 postmenopausal perfect health 0 1 -0.1 1
GSM1061080 1 ductal 2 1 1 48 10 premenopausal minor 0 0 -2.5 1
GSM1061079 1 ductal 2 equivocal 2 58 30 postmenopausal minor 0 1 0.2 1
GSM1061078 1 ductal 2 equivocal 2 47 17 premenopausal minor 0 0 -0.1 1
GSM1061077 1 ductal 1 equivocal 3 71 42 postmenopausal minor 0 0 0.1 1
GSM1061076 0 ductal 1 equivocal 2 71 12 postmenopausal average for age 0 0 -0.1 0
GSM1061075 1 ductal 1 3 3 78 42 postmenopausal average for age 1 0 0.6 1
GSM1061074 1 ductal 1 equivocal 2 49 15 premenopausal minor 0 0 -0.2 1
GSM1061073 1 ductal 1 3 3 55 12 postmenopausal average for age 0 0 1.3 1
GSM1061072 1 ductal 1 3 3 73 40 postmenopausal average for age 0 3 1.5 1
GSM106107 1 ductal 1 1 1 42 41 premenopausal perfect health 0 0 -0.8 1
GSM1061070 1 ductal 1 equivocal 1 81 14 postmenopausal major problems 0 0 -0.2 1
GSM1061069 1 ductal 6 equivocal 3 42 17 premenopausal minor 0 0 0.2 1
GSM1061068 1 lobular 6 equivocal 1 78 19 postmenopausal average for age 0 0 -0.3 1
GSM1061067 1 ductal 6 3 3 53 21 premenopausal perfect health 0 1 0.4 1
GSM1061066 0 ductal 9 1 2 50 15 postmenopausal perfect health 1 0 -0.3 1
GSM1061065 0 ductal 9 3 2 39 13 premenopausal perfect health 0 0 2.4 0
GSM1061064 1 lobular 9 equivocal 2 53 28 postmenopausal perfect health 0 3 -0.2 1
GSM1061063 1 ductal 9 3 3 41 28 premenopausal perfect health 0 1 1.5 1
GSM1061062 0 ductal 9 3 3 46 32 premenopausal perfect health 0 0 3.1 0
GSM106106 0 ductal 3 1 1 66 9 postmenopausal minor 0 0 -2 1
GSM1061060 0 ductal 3 3 3 69 21 postmenopausal major problems 0 0 3.1 0
GSM1061059 1 ductal 3 3 2 60 24 postmenopausal major problems 0 0 0.6 1
GSM1061058 1 lobular 3 3 3 54 35 postmenopausal minor 0 0 0.9 1
GSM1061057 1 ductal 3 3 3 71 19 postmenopausal NA 0 0 1.5 1
GSM1061056 1 ductal 3 equivocal 1 76 24 postmenopausal average for age 0 0 -0.2 1
GSM1061055 1 ductal 3 equivocal 1 78 18 postmenopausal perfect health 0 0 -0.3 1
GSM1061054 1 ductal 8 1 3 73 44 postmenopausal perfect health 0 3 -0.6 1
GSM1061053 0 ductal 2 3 3 48 11 premenopausal minor 0 0 1.2 0
GSM1061052 1 ductal 2 equivocal 2 56 16 postmenopausal minor 1 2 0.3 1
GSM106105 1 ductal 2 1 2 77 11 postmenopausal minor 0 1 -1 1
GSM1061050 1 ductal 2 1 2 51 28 premenopausal minor 0 1 -1.5 1
GSM1061049 1 ductal 2 1 1 67 18 postmenopausal minor 0 0 -2.3 1
GSM1061048 1 ductal 2 equivocal 2 48 10 premenopausal perfect health 0 0 0 1
GSM1061047 1 ductal 6 1 3 67 18 postmenopausal perfect health 0 1 -0.4 1
GSM1061046 0 ductal 6 3 2 66 50 postmenopausal perfect health 0 0 0.7 1
GSM1061045 1 ductal 6 1 1 72 11 postmenopausal minor 0 3 -1.8 1
GSM1061044 1 ductal 6 1 2 53 12 NA perfect health 0 0 -1.3 1
GSM1061043 0 ductal 6 3 3 54 45 postmenopausal minor 1 0 1.5 0
GSM1061042 0 ductal 6 3 2 61 10 postmenopausal perfect health 0 0 0.6 1
GSM106104 1 lobular 1 equivocal 2 81 15 postmenopausal major problems 0 0 0.1 1
GSM1061040 1 ductal 1 equivocal 2 47 13 premenopausal minor 0 0 0 1
GSM1061039 0 ductal 1 3 3 90 18 postmenopausal NA NA 0 0.4 0
GSM1061038 1 lobular 1 1 2 61 11 postmenopausal minor 0 0 -0.8 1
GSM1061037 1 lobular 1 1 1 76 16 postmenopausal average for age 0 0 -2.2 1
GSM1061036 0 ductal 1 3 3 43 19 NA perfect health 0 0 2.5 0
GSM1061035 1 ductal 1 1 2 65 30 postmenopausal average for age 0 0 -0.6 1
GSM1061034 0 ductal 4 3 2 59 10 postmenopausal average for age 1 0 0.5 0
GSM1061033 1 ductal 4 3 2 60 22 postmenopausal major problems 0 0 2.2 1
GSM1061032 1 ductal 6 3 2 68 17 postmenopausal perfect health 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use